Research output per year
Research output per year
Search results
-
2023
Can haematological changes constitute a surrogate diagnostic parameter to detect schistosomiasis in migrants and travellers? - A retrospective analysis
Schnyder, J. L., Gobbi, F., Schunk, M., Lindner, A., Salvador, F., Duvignaud, A., Arsuaga Vicente, M., Dejon Agobé, J. C., Cattaneo, P., Bertoli, G., Rothe, C., Wintel, M., Pou, D., Malvy, D., Adegnika, A. A., de Jong, H. K. & Grobusch, M. P., 1 Jun 2023, In: New Microbes and New Infections. 53, 101136.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus) -
COVID-19 impact on EuroTravNet infectious diseases sentinel surveillance in Europe
for EuroTravNet, 1 May 2023, In: Travel medicine and infectious disease. 53, 102583.Research output: Contribution to journal › Article › Academic › peer-review
Open Access3 Citations (Scopus) -
On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives
Schnyder, J. L., de Jong, H. K., Bache, E. B., van Hest, R. M., Schlagenhauf, P., Borrmann, S., Hanscheid, T. & Grobusch, M. P., 1 Mar 2023, In: Travel medicine and infectious disease. 52, p. 102520 102520.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus) -
2022
Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research
Schnyder, J. L., de Jong, H. K., Schlagenhauf, P., Borrmann, S., Hanscheid, T. & Grobusch, M. P., 1 Sept 2022, In: Travel medicine and infectious disease. 49, 102365.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access1 Citation (Scopus) -
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
HERALD Study Group, 1 Mar 2022, In: Lancet infectious diseases. 22, 3, p. 329-340 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access88 Citations (Scopus) -
Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy
Garcia Garrido, H. M., Schnyder, J. L., Haydari, B., Vollaard, A. M., Tanck, M. W. T., de Bree, G. J., Meek, B., Grobusch, M. P. & Goorhuis, A., 1 Aug 2022, In: International Journal of Antimicrobial Agents. 60, 2, 106629.Research output: Contribution to journal › Article › Academic › peer-review
Open Access4 Citations (Scopus) -
Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
Schnyder, J. L., de Jong, H. K. & Grobusch, M. P., Jan 2022, In: Clinical Microbiology and Infection. 28, 1, p. 6-8 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access3 Citations (Scopus) -
2021
Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: A systematic review
Schnyder, J. L., Garcia Garrido, H. M., de Pijper, C. A., Daams, J. G., Stijnis, C., Goorhuis, A. & Grobusch, M. P., 1 May 2021, In: Travel medicine and infectious disease. 41, 102007.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access12 Citations (Scopus) -
Correspondence delayed large local reaction to the adenovirus-vectored (ChAdOx1) vaccine
Grobusch, M. P., Schnyder, J., Garcia-Garrido, H. M., Wisman, J. J., Stijnis, C., Goorhuis, A., Hänscheid, T. & de Jong, H. K., 1 Sept 2021, In: Travel medicine and infectious disease. 43, 102093.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access4 Citations (Scopus)